BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: Correlation with biological and clinical features

被引:44
作者
Bojarska-Junak, Agnieszka [1 ]
Hus, Iwona [2 ]
Chocholska, Sywia [2 ]
Wasik-Szczepanek, Ewa [2 ]
Sieklucka, Malgorzata [1 ]
Dmoszynska, Anna [2 ]
Rolinski, Jacek [1 ]
机构
[1] Med Univ Lublin, Dept Clin Immunol, PL-20954 Lublin, Poland
[2] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, PL-20954 Lublin, Poland
关键词
B-CLL; BAFF; APRIL; ZAP-70; CD38; ZAP-70; EXPRESSION; TACI; AUTOIMMUNITY; STIMULATOR; DIAGNOSIS; MECHANISM; MYELOMA;
D O I
10.1016/j.leukres.2009.03.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are involved in normal B cell survival and differentiation. We analyzed BAFF and APRIL plasma levels in patients with B-cell chronic lymphocytic leukemia (B-CLL). We also tested intracellular BAFF and APRIL expression in B-CLL and evaluated their prognostic relevance. The percentage of leukemic B cells with intracellular APRIL or BAFF expression correlated significantly with adverse prognostic factors such as ZAP-70 and CD38. Moreover, we found a close relationship between LPL protein expression or LPL/ADAM29 MFI ratio and proportion of B-CLL cells with intracellular BAFF or APRIL expression. Furthermore, patients with a low percentage of leukemic cells with intracellular BAFF or APRIL expression had a significantly longer overall survival than those with a high proportion of APRIL or BAFF positive leukemic cells. (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 28 条
[1]  
Bojarska-Junak A, 2005, FOLIA HISTOCHEM CYTO, V43, P19
[2]   Comparison of methods for determining zeta-chain associated protein-70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL) [J].
Bojarska-Junak, Agnieszka ;
Giannopoulos, Krzysztof ;
Kowal, Malgorzata ;
Dmoszynska, Anna ;
Rolinski, Jacek .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2006, 70B (04) :293-301
[3]   BAFF, APRIL and their receptors: Structure, function and signaling [J].
Bossen, Claudia ;
Schneider, Pascal .
SEMINARS IN IMMUNOLOGY, 2006, 18 (05) :263-275
[4]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[5]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[6]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[7]   ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia [J].
Dürig, J ;
Nückel, H ;
Cremer, M ;
Führer, A ;
Halfmeyer, K ;
Fandrey, J ;
Möröy, T ;
Klein-Hitpass, L ;
Dührsen, U .
LEUKEMIA, 2003, 17 (12) :2426-2434
[8]   Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics [J].
Ekstrom Smedby, Karin ;
Baecklund, Eva ;
Askling, Johan .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) :2069-2077
[9]   Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia [J].
Haiat, Stephanie ;
Billard, Christian ;
Quiney, Claire ;
Ajchenbaum-Cymbalista, Florence ;
Kolb, Jean-Pierre .
IMMUNOLOGY, 2006, 118 (03) :281-292
[10]   Autoimmune complications of chronic lymphocytic leukemia [J].
Hamblin, TJ .
SEMINARS IN ONCOLOGY, 2006, 33 (02) :230-239